Enhanced hyaluronan synthesis in the MRL-FasIpr kidney:: Role of cytokines

被引:41
作者
Feusi, E
Sun, LK
Sibalic, A
Beck-Schimmer, B
Oertli, B
Wüthrich, RP
机构
[1] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland
[2] Univ Zurich Hosp, Dept Anesthesiol, CH-8091 Zurich, Switzerland
[3] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland
来源
NEPHRON | 1999年 / 83卷 / 01期
关键词
hyaluronan; CD44; lupus nephritis; mouse;
D O I
10.1159/000045475
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background/Aim: Pathological accumulation of the extracellular matrix component hyaluronan (HA) occurs in the kidney cortex in immune-system mediated tissue injury. The purpose of the present study was to examine the pattern of HA deposition and the mechanisms of HA synthesis in the MRL-Fas(lpr) mouse model of lupus nephritis. Methods: Kidneys from normal and autoimmune mice were examined for HA content by immunofluorescence staining. Steady state mRNA levels for key enzymes involved in HA synthesis - uridine diphosphate-glucose dehydrogenase (UDPGDH) and HA synthases (HAS) 1, 2 and 3 - were assessed by reverse-transcriptase polymerase chain reaction (RT-PCR). Using cultured mouse tubular epithelial cells, the regulation of the HA production in vitro in response to tumor necrosis factor alpha and interferon gamma was also examined. Results: By immunofluorescence staining, large amounts of HA were detected in the cortical interstitium of MRL-Fas(lpr) mice with autoimmune renal injury, but not in congenic MRL-++ mice. By RT-PCR the presence of transcripts for several genes involved in the synthesis of HA in normal and autoimmune kidneys could be demonstrated, including mRNA for UDPGDH and HAS1 and HAS2, but not for HAS3. Except for HAS2, steady state mRNA levels for these enzymes did not correlate with disease activity. Analyzing a kidney tubular epithelial cell line in vitro, it was found that tumor necrosis factor alpha and interferon gamma, and particularly the combination of these two cytokines, markedly enhanced the synthesis of HA. The expression of HAS2 mRNA was also enhanced in response to cytokine treatment. Conclusions: HA deposition is prominent in MRL-Fas(lpr) mice with renal disease and could be mediated by local synthesis through HAS1 and HAS2. We hypothesize that the enhanced synthesis of HA could be promoted by proinflammatory cytokines in vivo. The functional significance of HA accumulation in autoimmune renal injury remains to be determined.
引用
收藏
页码:66 / 73
页数:8
相关论文
共 32 条
[1]  
Beck-Schimmer B, 1998, J AM SOC NEPHROL, V9, P2283
[2]   Enhanced tubular epithelial CD44 expression in MRL-lpr lupus nephritis [J].
Benz, PS ;
Fan, XH ;
Wuthrich, RP .
KIDNEY INTERNATIONAL, 1996, 50 (01) :156-163
[3]  
BOSWELL JM, 1988, J IMMUNOL, V141, P3050
[4]  
FAABER P, 1984, CLIN EXP IMMUNOL, V55, P502
[5]   Upregulation of lymphoid and renal interferon-gamma mRNA in autoimmune MRL-Fas(lpr) mice with lupus nephritis [J].
Fan, XH ;
Wuthrich, RP .
INFLAMMATION, 1997, 21 (01) :105-112
[6]   VARIOUS RAT ADULT TISSUES EXPRESS ONLY ONE MAJOR MESSENGER-RNA SPECIES FROM THE GLYCERALDEHYDE-3-PHOSPHATE-DEHYDROGENASE MULTIGENIC FAMILY [J].
FORT, P ;
MARTY, L ;
PIECHACZYK, M ;
ELSABROUTY, S ;
DANI, C ;
JEANTEUR, P ;
BLANCHARD, JM .
NUCLEIC ACIDS RESEARCH, 1985, 13 (05) :1431-1442
[7]  
GREEN SJ, 1988, J CELL SCI, V90, P145
[8]   HYALURONIC-ACID ACCUMULATION AND REDISTRIBUTION IN REJECTING RAT-KIDNEY GRAFT - RELATIONSHIP TO THE TRANSPLANTATION EDEMA [J].
HALLGREN, R ;
GERDIN, B ;
TUFVESON, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (06) :2063-2076
[9]   CHARACTERIZATION OF A RENAL TUBULAR EPITHELIAL-CELL LINE WHICH SECRETES THE AUTOLOGOUS TARGET ANTIGEN OF AUTOIMMUNE EXPERIMENTAL INTERSTITIAL NEPHRITIS [J].
HAVERTY, TP ;
KELLY, CJ ;
HINES, WH ;
AMENTA, PS ;
WATANABE, M ;
HARPER, RA ;
KEFALIDES, NA ;
NEILSON, EG .
JOURNAL OF CELL BIOLOGY, 1988, 107 (04) :1359-1368
[10]   Expression cloning and molecular characterization of HAS protein, a eukaryotic hyaluronan synthase [J].
Itano, N ;
Kimata, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (17) :9875-9878